Factor V levels and risk of venous thrombosis: The MEGA case-control study-Reference-Cited by-同舟云学术

Factor V levels and risk of venous thrombosis: The MEGA case-control study

Published:2018-04 Issue:2 Volume:2 Page:320-326
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Rietveld Inge M.¹²,Bos Mettine H. A.¹²,Lijfering Willem. M.¹²³,Li-Gao Ruifang³^ORCID,Rosendaal Frits R.¹³,Reitsma Pieter H.¹²,Cannegieter Suzanne C.²³^ORCID

Affiliation:

1. Einthoven Laboratory for Experimental Vascular Medicine; Leiden University Medical Center; Leiden The Netherlands

2. Department of Thrombosis and Haemostasis; Leiden University Medical Center; Leiden The Netherlands

3. Department of Clinical Epidemiology; Leiden University Medical Center; Leiden The Netherlands

Funder

Netherlands Heart Foundation

Dutch Cancer Foundation

Netherlands Organization for Scientific Research

Stichting voor de Technische Wetenschappen

Center for Translational Molecular Medicine

Publisher

Wiley

Subject

Hematology

Reference23 articles.

1. Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study;Liao;J Thromb Haemost,2014

2. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study;Anderson;Arch Intern Med,1991

3. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis;Poort;Blood,1996

4. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE);Tsai;Am J Med,2002

5. Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis;Visser;Thromb Haemost,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetic analysis of prothrombinase assembly and substrate delivery mechanisms;Journal of Theoretical Biology;2024-11

2. Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation;Current Opinion in Hematology;2024-08-27

3. A genome wide search for non-additive allele effects identifiesPSKH2as involved in the variability of Factor V activity;2024-02-09

4. Membrane binding and lipid-protein interaction of the C2 domain from coagulation factor V;Current Research in Structural Biology;2024

5. Factor V variants in bleeding and thrombosis;Research and Practice in Thrombosis and Haemostasis;2024-01